Z-0632-2013 Class II Terminated

Recalled by Horiba Instruments, Inc Dba Horiba Medical — Irvine, CA

FDA device recall Z-0632-2013 was initiated by Horiba Instruments, Inc Dba Horiba Medical on Oct 10, 2012 and is designated Class II. Reason for recall: Horiba Medical is recalling the ABX PENTRA AST CP because during the AST application validation on the Pentra C200 using an Audit Systems linearity kit, it was determined that two higher values for… The recall status is terminated (terminated Sep 12, 2013). Affected quantity: 66886 units.

Recall details

Product Type
Devices
Report Date
Jan 9, 2013
Initiation Date
Oct 10, 2012
Termination Date
Sep 12, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
66886 units

Product description

ABX PENTRA AST CP, Part Number: A11A01629. The ABX Pentra AST CP reagent is a diagnostic reagent for quantitative in vitro determination of Aspartate Amino Transferase (AST) in serum or plasma by colorimetry.

Reason for recall

Horiba Medical is recalling the ABX PENTRA AST CP because during the AST application validation on the Pentra C200 using an Audit Systems linearity kit, it was determined that two higher values for AST (expected at 800 U/L and 1000 U/L) were recorded at 280 and 199 U/L without alarm.

Distribution pattern

Nationwide Distribution including CA, OK, NY, FL, AZ, NY, VA, and TX.

Code information

Lot number: 00456-4108

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0632-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0632-2013. Report a data issue: hello@regdatalab.com.